Top of page Skip navigation
Abzena is a life sciences group with its headquarters in the UK and two sites in the US. Abzena offers a range of complementary services and technologies for the selection, development and manufacture of biopharmaceuticals, products based on antibodies or other proteins.
 

A global pharmaceutical company with a major UK presence. Our purpose is to push the boundaries of science to deliver life-changing medicines. The best way we can help patients is to be science-led and share this passion with the scientific, healthcare and business communities of the UK.

 
Our name combines these ideas. As the world’s #1 drug development, delivery and supply partner with over 80 years of experience, we are the catalyst for your success. We have helped thousands of innovators by optimizing and manufacturing thousands of pharmaceutical, biologic, consumer health and beauty products utilizing our superior and innovative drug delivery technologies to improve their value to patients and consumers. And Catalent’s “Patient First” culture puts patients at the center of our work to ensure the safety, reliable supply and optimal performance of our products. 
LifeArc (the new name for MRC Technology) is a medical research charity with a 25 year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients.

LifeArc is pioneering new ways to turn great science into greater patient impact. It brings together a network of partners to tackle specific diseases and directly funds academic and early stage research.

So far, LifeArc’s work has helped to develop four drugs (Keytruda®, Actemra®, Tysabri® and Entyvio®) and a test for antimicrobial resistance.

With one of the largest, most robust pipelines in the industry — including more than 120 research projects and product candidates — we comprise nearly half of AstraZeneca’s overall R&D portfolio. We are focused on three core therapeutic areas: Oncology; Respiratory, Inflammation and Autoimmune; and Cardiovascular and Metabolic Disease. But, we also are opportunity-driven in Infectious Disease.
 What really sets Mills & Reeve apart from other law firms is the way we work with you. We understand that clients no longer want a traditional law firm in the 21st century – you want one that embraces forward thinking approaches to service, billing, commercial know-how, innovation, people management and community engagement. 

And what about our actual legal advice? Our concise approach helps to solve the most complex of legal problems. Mills & Reeve routinely performs world-class work for our world-class clients. 
 

 

 


TranScrip mitigates the risk of drug development and maximises opportunities by staying at the cutting edge of therapeutic and regulatory understanding.... a trusted partner of almost half of the top 50 pharma and many more small organisations.

TranScrip is a global organisation fielding multi-functional talented teams with in-depth therapeutic, strategic and operational expertise integrating seamlessly into pharma supporting products at all stages of development and commercialisation. Projects span early development planning including positioning, translational science, full clinical development, regulatory, drug safety and PV, medical affairs and commercial activities. TranScrip help to build and defend valuable pipelines, delivering on expectation.

www.transcrip-partners.com

paul.branthwaite@transcrip-partners.com

0118 963 7846

@TranScripPtnrs

 
   
   
   
   
   
   
   
   
   
   

 


Headline Sponsor





Sponsors









Session Sponsor